Colcrys FDA Approval History
FDA Approved: Yes (First approved July 29, 2009)
Brand name: Colcrys
Generic name: colchicine
Dosage form: Tablets
Company: Mutual Pharmaceutical Company, Inc.
Treatment for: Gout, Familial Mediterranean Fever, Gout, Prophylaxis, Gout, Acute
Colcrys (colchicine) is compound derived from the dried seeds of the autumn crocus or meadow saffron (Colchicum autumnale). Colcrys is approved for the prophylaxis and treatment of acute gout flares, and for the treatment of patients with familial Mediterranean fever.
Development timeline for Colcrys
| Date | Article |
|---|---|
| Oct 22, 2009 | Approval FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares |
| Jul 31, 2009 | Approval FDA Approves Colcrys (colchicine) for Acute Gout, Mediterranean Fever |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
